Language

Medicine shortages: Belgium · Page 5

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 5 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 5

Belgium

Relestat 0.5 mg/ml eye drops sol. 5 ml

Marketing ended · Commercial reasons
Active ingredient: Epinastine

Notice details →
Belgium

Reparil 1 % gel 100 g

Available again · Not specified
Active ingredient: Diethylamine Salicylate,Escin

Notice details →
Belgium

Rivotril 2 mg (Impexeco) tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Clonazepam

Notice details →
Belgium

Rosuvastatin Sandoz 10 mg film-coat. tabl. 100

Available again · Not specified
Active ingredient: Rosuvastatin

Notice details →
Belgium

Sertraline Sandoz 100 mg film-coat. tabl. 100

Available again · Not specified
Active ingredient: Sertraline

Notice details →
Belgium

Sertraline Sandoz 100 mg film-coat. tabl. 60

Available again · Not specified
Active ingredient: Sertraline

Notice details →
Belgium

Sertraline Sandoz 50 mg film-coat. tabl. 100

Available again · Not specified
Active ingredient: Sertraline

Notice details →
Belgium

Simvastatine Teva 80 mg film-coat. tabl. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Simvastatin

Notice details →
Belgium

Steovit Forte Citron 1 000 mg - 800 IU chewable tabl. 50 (50 x 1) UD

Nicht verfügbar · Delay in final product release
Active ingredient: Calcium,Cholecalciferol

Notice details →
Belgium

Tadalafil AB 20 mg (PI Pharma) film-coat. tabl. 28

Nicht verfügbar · Sonstige
Active ingredient: Tadalafil

Notice details →
Belgium

Tadalafil EG 20 mg (PI Pharma) film-coat. tabl. 12 (12 x 1) UD

Nicht verfügbar · Sonstige
Active ingredient: Tadalafil

Notice details →
Belgium

Tamsulosine Sandoz 0.4 mg (PI Pharma) hard caps. modif.-rel. 200

Nicht verfügbar · Sonstige
Active ingredient: Tamsulosin Hydrochloride

Notice details →
Belgium

Terbinafin AB 250 mg tabl. 56

Nicht verfügbar · Sonstige
Active ingredient: Terbinafine

Notice details →
Belgium

Tiberal 1 g/6 ml inf. sol. (conc.) i.v. amp. 6 ml

Nicht verfügbar · Delay in final product release
Active ingredient: Ornidazole

Notice details →
Belgium

Topamax 25 mg film-coat. tabl. 100

Available again · Not specified
Active ingredient: Topiramate

Notice details →
Belgium

Venlafaxin Retard Sandoz 150 mg hard caps. prol.-rel. 98

Available again · Not specified
Active ingredient: Venlafaxine

Notice details →
Belgium

Visipaque 270 mg I/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 100 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Iodixanol

Notice details →
Belgium

Zofsetron 8 mg/4 ml inj. sol. i.m./i.v. amp. 5 x 4 ml

Marketing ended · Commercial reasons
Active ingredient: Ondansetron

Notice details →
Belgium

Amlodipin Besilaat Sandoz 10 mg (PI Pharma) tabl. 100

Marketing ended · Sonstige
Active ingredient: Amlodipine

Notice details →
Belgium

Arcoxia 60 mg (PI Pharma) film-coat. tabl. 28

Nicht verfügbar · Sonstige
Active ingredient: Etoricoxib

Notice details →
Belgium

Atorvastatine Teva Pharma 40 mg (PI Pharma) film-coat. tabl. 100

Marketing ended · Sonstige
Active ingredient: Atorvastatin

Notice details →
Belgium

Brintellix 10 mg (PI Pharma) film-coat. tabl. 28

Nicht verfügbar · Sonstige
Active ingredient: Vortioxetine

Notice details →
Belgium

Brintellix 20 mg (PI Pharma) film-coat. tabl. 28

Nicht verfügbar · Sonstige
Active ingredient: Vortioxetine

Notice details →
Belgium

Bronchodine 10 mg/5 ml syrup 180 ml

Marketing ended · Revocation of the authorisation
Active ingredient: Codeine Phosphate Hemihydrate

Notice details →
Belgium

Casodex 50 mg (PI Pharma) film-coat. tabl. 28

Available again · Not specified
Active ingredient: Bicalutamide

Notice details →
Belgium

Cetavlex 1 mg/g cream 60 g

Marketing ended · Active ingredient not available
Active ingredient: Cetrimonium Bromide ,Chlorhexidine Digluconate

Notice details →
Belgium

Concerta 54 mg (PI Pharma) tabl. prol.-rel. 30

Nicht verfügbar · Sonstige
Active ingredient: Methylphenidate Hydrochloride

Notice details →
Belgium

Coveram 5 mg - 10 mg tabl. 90

Nicht verfügbar · Delay in final product release
Active ingredient: Amlodipine,Perindopril

Notice details →
Belgium

Dafalgan 500 mg (PI Pharma) efferv. tabl. 40

Available again · Not specified
Active ingredient: Paracetamol

Notice details →
Belgium

Daphne 2 mg - 0.035 mg coat. tabl. 13 x 21

Nicht verfügbar · Manufacturing delay
Active ingredient: Ethinylestradiol,Cyproterone acetate

Notice details →
Belgium

Daphne 2 mg - 0.035 mg coat. tabl. 6 x 21

Nicht verfügbar · Manufacturing delay
Active ingredient: Ethinylestradiol,Cyproterone acetate

Notice details →
Belgium

Desoceane 75 µg film-coat. tabl. 6 x 28

Marketing ended · Commercial reasons
Active ingredient: Desogestrel

Notice details →
Belgium

Desorelle 30 150 µg - 30 µg film-coat. tabl. 6 x 21

Marketing ended · Commercial reasons
Active ingredient: Ethinylestradiol,Desogestrel

Notice details →
Belgium

Domperidone Instant EG 10 mg (PI Pharma) orodisp. tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Domperidone

Notice details →
Belgium

Dotarem 0.5 mmol/ml inj. sol. i.v. vial 60 ml

Available again · Not specified
Active ingredient: Gadoteric Acid

Notice details →
Belgium

Drosana 20 0.02 mg - 3 mg film-coat. tabl. 13 x 21

Marketing ended · Commercial reasons
Active ingredient: Drospirenone,Ethinylestradiol

Notice details →
Belgium

Drosana 20 0.02 mg - 3 mg film-coat. tabl. 3 x 21

Marketing ended · Commercial reasons
Active ingredient: Drospirenone,Ethinylestradiol

Notice details →
Belgium

Drosana 20 0.02 mg - 3 mg film-coat. tabl. 6 x 21

Marketing ended · Commercial reasons
Active ingredient: Drospirenone,Ethinylestradiol

Notice details →
Belgium

Drosana 30 0.03 mg - 3 mg film-coat. tabl. 13 x 21

Marketing ended · Commercial reasons
Active ingredient: Ethinylestradiol,Drospirenone

Notice details →
Belgium

Drosana 30 0.03 mg - 3 mg film-coat. tabl. 3 x 21

Marketing ended · Commercial reasons
Active ingredient: Ethinylestradiol,Drospirenone

Notice details →
Belgium

Drosana 30 0.03 mg - 3 mg film-coat. tabl. 6 x 21

Marketing ended · Commercial reasons
Active ingredient: Ethinylestradiol,Drospirenone

Notice details →
Belgium

Elocom 0.1 % cream 100 g

Available again · Not specified
Active ingredient: Mometasone Furoate

Notice details →
Belgium

Ezetrol 10 mg tabl. 98

Available again · Not specified
Active ingredient: Ezetimibe

Notice details →
Belgium

Flammazine 1 % (PI Pharma) cream 50 g

Available again · Not specified
Active ingredient: Sulfadiazine Silver

Notice details →
Belgium

Forzaten 20 mg - 5 mg (PI Pharma) film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Amlodipine ,Olmesartan Medoxomil

Notice details →
Belgium

Gaviscon Adapted Formulation Mint 250 mg chewable tabl. 48

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Alginate,Calcium Carbonate,Sodium Hydrogen Carbonate

Notice details →
Belgium

Lambipol 200 mg (PI Pharma) chewable tabl./disp. tabl. 60

Available again · Not specified
Active ingredient: Lamotrigine

Notice details →
Belgium

Lamictal 200 mg (PI Pharma) chewable tabl./disp. tabl. 30

Available again · Not specified
Active ingredient: Lamotrigine

Notice details →
Belgium

Lindynette 20 0.02 mg - 0.075 mg coat. tabl. 6 x 21

Marketing ended · Commercial reasons
Active ingredient: Ethinylestradiol,Gestodene

Notice details →
Belgium

Litican 50 mg/2 ml inj. sol. i.m./i.v. amp. 6 x 2 ml

Marketing ended · Commercial reasons
Active ingredient: Alizapride

Notice details →